DUCTAL BREAST CARCINOMA IN SITU
Clinical trials for DUCTAL BREAST CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new DUCTAL BREAST CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for DUCTAL BREAST CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Proton beam radiation aims to spare healthy tissue in breast cancer treatment
Disease control OngoingThis phase II trial is testing a type of radiation called proton beam therapy for women with early-stage breast cancer (stage 0 to II). The goal is to see if this targeted approach can kill cancer cells while causing less damage to normal tissue, leading to fewer side effects and…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a one-week radiation zap be just as good as three weeks for early breast cancer?
Disease control OngoingThis study compares a 1-week radiation schedule to the standard 3.1-week schedule for people with early-stage breast cancer who have had lumpectomy. The goal is to see if the shorter course controls cancer just as well while causing fewer side effects. About 72 adults with ductal…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: Coordinación de Investigación en Salud, Mexico • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New radiation approach aims to cut treatment time and side effects for breast cancer
Disease control TerminatedThis study tests a shorter, more focused radiation treatment (hypofractionated partial breast irradiation) for women with early-stage breast cancer. The goal is to see if targeting only the tumor site can reduce side effects and improve cosmetic outcomes compared to standard whol…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Robots take on breast cancer surgery in tiny pilot trial
Disease control OngoingThis pilot study tested whether a robot-assisted surgical technique (using the daVinci system) can safely remove breast tissue while sparing the nipple in people with early-stage breast cancer or those needing preventive mastectomy. Only 4 participants were enrolled, and the stud…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a common diabetes drug stop breast cancer before it starts?
Prevention OngoingThis phase 3 trial tests whether taking metformin for 12 months can reduce abnormal cells in the breast tissue of women at high risk for breast cancer. Participants have conditions like atypical hyperplasia or a strong family history. Researchers compare metformin to a placebo to…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Hunger training may help cut breast cancer risk in obese women
Prevention OngoingThis pilot study looks at whether adding hunger training to a standard diabetes prevention program helps obese women at high risk for breast cancer lose weight and lower their cancer risk. About 51 participants will learn weight-loss strategies and how to recognize true hunger. T…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Shorter radiation course may spare breast cancer patients side effects
Symptom relief OngoingThis study tests whether a shorter course of higher-dose radiation (hypofractionated) is as good as or better than standard radiation for early-stage breast cancer. About 300 women with ductal carcinoma in situ or early invasive breast cancer are participating. The main goal is t…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can MRI and gene tests help avoid unnecessary mastectomies?
Knowledge-focused OngoingThis study looks at whether combining MRI scans with genetic testing can help doctors choose the best treatment for people with ductal carcinoma in situ (DCIS), a very early form of breast cancer that hasn't spread. About 368 participants will have an MRI and a genetic test on th…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Can a gel fight breast cancer? new study tests skin absorption after radiation
Knowledge-focused OngoingThis study looks at how well a medicated gel (afimoxifene) is absorbed through the skin of the breast in women who have had radiation for breast cancer. Researchers want to understand if differences in skin type or past radiation change how much gel gets into the breast tissue. T…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC